Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Tyring SK, Kircik LH, Pariser DM, et al
Hiemstra PS, Amatngalim GD, Does AMVD, Taube C
PLoS One 14(7):e0218919
GHK-Cu is a synthetic copper-binding tripeptide complex composed of glycyl-L-histidyl-L-lysine and copper(II)
The product is manufactured in GMP & ISO-certified facilities and complies with FSSAI standards , ensuring safety, purity, and consistency
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
US$ 20.90
US$ 27.51
US$ 28.34
US$ 22.61
